Dow Up 0.01% Nasdaq  0.00%

Search for share prices

Finance SearchTue, Dec 8, 2009, 4:41AM ET - U.S. Markets open in 4 hours and 49 minutes.
Dec 7: 0.9401   0.00 (0.00%)  

AEterna Zentaris Inc. (AEZS)

Compare AEZS to:

    • Dow Jones (^DJI)
    • NASDAQ (^IXIC)
    • S&P 500 (^GSPC)

    AEterna Zentaris, Inc.

    (NasdaqGM: AEZS)

    After Hours: 0.00 N/A (N/A) 7:00pm ET

    Last Trade:0.9401
    Trade Time:Dec 7
    Change: 0.00 (0.00%)
    Prev Close:0.9401
    Open:N/A
    Bid:0.76 x 500
    Ask:0.99 x 2000
    1y Target Est:1.61
    Day's Range:N/A - N/A
    52wk Range:0.32 - 3.25
    Volume:0
    Avg Vol (3m):652,088
    Market Cap:59.31M
    P/E (ttm):N/A
    EPS (ttm):-0.938
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. For consolidated real-time quotes (incl. pre/post market data), sign up for a free trial of Real-time Quotes.
    Headlines
    Mon 8:35amAEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of HematologyPR Newswire
    Mon 8:30amKeryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of HematologyPR Newswire
    Mon 7:40amAEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic HyperplasiaPR Newswire
    Wed, Dec 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple MyelomaPR Newswire
    Wed, Dec 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple MyelomaPR Newswire
    Tue, Nov 24Emerging Stock Report Initiates Independent Research Coverage on AEterna Zentaris Inc.GlobeNewswire
    Tue, Nov 24Tellabs, Zagg: Early Volume Playsat TheStreet.com
    Tue, Nov 24AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial CancerPR Newswire
    Thu, Nov 12New Star Analyst Rankings for AEterna Zentaris, Inc.StarMine
    Wed, Nov 11AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of HematologyPR Newswire

    Sponsored Links

    Obama Urges Homeowners to Refinance
    ($90,000 Refinance $489/mo) See Rates - No Credit Check Req.
    www.SeeRefinanceRates.com
    Top Online School Degrees
    Earn Your Degree from a Top School Online! Study at Home or Anywhere.
    CollegeDegreeNetwork.com/Schools
    Health Insurance Quotes
    America's #1 Health Insurance Site. Compare the Best Plans Instantly.
    eHealthInsurance.com
    Get Your Degree in the Arts
    Your Passion, a Degree, a Career. Learn Design, Media, Fashion, More.
    www.ArtBistro.com/Degrees
    Become A Police Officer
    SWAT, K9, Narcotics, CSI & More. Online Degrees For Police Careers.
    Public-Service.com/PoliceCareers
    Donate Your Car
    Any Condition! Fast, Easy, and Tax Deductible. Choose Your Charity Now.
    www.clikpath.net/donate

    Quotes delayed, except where indicated otherwise.
    Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.

    Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page.Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.Real-Time quotes provided by BATS Exchange.Financials data provided by Edgar Online.Dividend data provided by Morningstar, Inc.Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI).International historical chart data, daily updates, fundFund summary, fund performance and Morningstar Index data provided by Morningstar.Analyst estimates data provided by Thomson Financial Network. All data povided by Thomson Financial Network is based solely upon research information provided by third party analysts. Yahoo! has not reviewed, and in no way endorses the validity of such data. Yahoo! and ThomsonFN shall not be liable for any actions taken in reliance thereon.All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.